aibioMHUAF Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co. (MHUAF) news
Meihua International Medical Technologies Co., Ltd. is a public biotech or pharmaceutical company listed on OTC under the ticker MHUAF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Meihua International Medical Technologies Co. news
We have not published a story on Meihua International Medical Technologies Co. yet. When there is news, it will appear here.
What Meihua International Medical Technologies Co. does
Meihua International Medical Technologies Co., Ltd. is a Cayman Islands holding company whose operations are conducted through subsidiaries in mainland China. Its subsidiary Yangzhou Huada manufactures and sells Class I disposable medical devices under its own brands, mainly non-bottled products such as brushes and ID bracelets for domestic sales, and also distributes disposable medical devices sourced from other manufacturers. Jiangsu Yada manufactures and sells Class I and Class II disposable medical devices and focuses on overseas sales. Jiangsu Huadong manufactures and sells Class I, II and III disposable medical devices, mainly polyethylene bottled products such as eye drop bottles and tablet bottles, to domestic and overseas customers. Hainan Ruiying is a trading and import-export company meant to facilitate the introduction of new medical technology, devices and equipment. Meihua Future, established in New York, is a software service company focused on SaaS development services. The company describes its corporate structure as a direct holding structure in which the listed Cayman entity controls its China operating subsidiaries through a Hong Kong company.
| Product or program | What it is | Stage |
|---|---|---|
| Disposable medical devices under own brands | Class I disposable devices such as brushes and ID bracelets | |
| Polyethylene bottled products | Eye drop bottles and tablet bottles made by Jiangsu Huadong |
Meihua International Medical Technologies Co. annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $61.8 million | $96.9 million |
| Research and development | $2.4 million | $3.5 million |
| Net income (loss) | $6.8 million | $10.8 million |
| Cash from operations | $569,883 | $14.6 million |
| Cash and equivalents | $15.2 million | $17.3 million |
Questions about Meihua International Medical Technologies Co.
What is the ticker symbol of Meihua International Medical Technologies Co.?
Meihua International Medical Technologies Co., Ltd. trades under the ticker MHUAF on OTC.
Where is Meihua International Medical Technologies Co. listed?
Meihua International Medical Technologies Co., Ltd. is listed on OTC.
Which country or territory is Meihua International Medical Technologies Co. listed under?
Our directory records Meihua International Medical Technologies Co., Ltd. under United States.
Does aibio.space cover Meihua International Medical Technologies Co.?
aibio.space lists Meihua International Medical Technologies Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What does Meihua International Medical Technologies Co. develop?
Meihua International Medical Technologies Co., Ltd. is a Cayman Islands holding company whose operations are conducted through subsidiaries in mainland China. Its subsidiary Yangzhou Huada manufactures and sells Class I disposable medical devices under its own brands, mainly non-bottled products such as brushes and ID bracelets for domestic sales, and also distributes disposable medical devices sourced from other manufacturers.
What is Disposable medical devices under own brands from Meihua International Medical Technologies Co.?
Disposable medical devices under own brands: Class I disposable devices such as brushes and ID bracelets
What is Polyethylene bottled products from Meihua International Medical Technologies Co.?
Polyethylene bottled products: Eye drop bottles and tablet bottles made by Jiangsu Huadong
What was Meihua International Medical Technologies Co.'s revenue last year?
$61.8 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Meihua International Medical Technologies Co. profitable?
Meihua International Medical Technologies Co., Ltd. reported net income of $6.8 million for the fiscal year ended Dec 31, 2025, and generated $569,883 of cash from operations, per its annual report to the SEC.
How much does Meihua International Medical Technologies Co. spend on research and development?
$2.4 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Meihua International Medical Technologies Co. have?
$15.2 million in cash at Dec 31, 2025, per its 20-F.
Investor discussion: Meihua International Medical Technologies Co.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Meihua International Medical Technologies Co., Ltd.
- Ticker
- MHUAF
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction